Your session is about to expire
← Back to Search
Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TFNA) for Non-Small Cell Lung Cancer
N/A
Recruiting
Led By Inderdeep Dhaliwal, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial will compare two methods of cancer treatment to see which is more effective in patients with non-small cell lung cancer.
Who is the study for?
This trial is for adults over 18 with Non-Small Cell Lung Cancer (NSCLC) who have undergone recent staging investigations. It's aimed at those with a good performance status, up to 5 metastases, and plans for radical treatment of all cancer sites. Pregnant women, individuals unable to consent, or those with contraindications to EBUS/EUS or chest radiotherapy cannot participate.Check my eligibility
What is being tested?
The study tests if sampling lymph nodes using EBUS-TFNA or EUS-FNA can better determine the extent of nodal disease in NSCLC compared to imaging alone. Participants will also receive Stereotactic Ablative Radiotherapy (SABR), a precise high-dose radiation therapy.See study design
What are the potential side effects?
Potential side effects from the procedures may include discomfort at the biopsy site, bleeding, infection risk from needle aspiration and general risks associated with anesthesia. SABR may cause skin irritation, fatigue, shortness of breath and other localized symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes to treatment intent and/or plan
Secondary outcome measures
Determine the proportion of patients with complications of endoscopic procedure
Determine the proportion of patients with occult mediastinal metastasis
Determine the sensitivity and specificity of radiologic staging of hilar/mediastinal lymph nodes
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment2 Interventions
Small pieces of suspicious chest lymph nodes will be removed with a procedure called endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TFNA) or transesophageal ultrasound-guided fine needle aspiration (EUS-FNA).
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
658 Previous Clinical Trials
413,629 Total Patients Enrolled
Academic Medical Organization of Southwestern OntarioOTHER
13 Previous Clinical Trials
2,520 Total Patients Enrolled
Inderdeep Dhaliwal, MDPrincipal InvestigatorLondon Health Sciences Centre, Lawson Health Research Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this experiment currently have vacancies for participants?
"Correct. The information available on clinicaltrials.gov declares that enrollment for this medical trial is in progress, which was initially posted on November 9th 2021 and recently revised the same day. A total of 29 individuals are needed across two different sites."
Answered by AI
How many individuals are currently eligible to participate in this trial?
"Affirmative, clinicaltrials.gov denotes that this research endeavour is currently recruiting subjects. It was established on November 9th 2021 and last amended the same day. The trial requires 29 volunteers between 2 sites to complete it successfully."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger